STRATEGIC PRE-CLINICAL PRODUCT DEVELOPMENT LIMITED
DURHAM

Hellopages » County Durham » County Durham » DH1 1TW

Company number 09234622
Status Active
Incorporation Date 25 September 2014
Company Type Private Limited Company
Address C/O WESTWATERS OAKMERE, BELMONT BUSINESS PARK, DURHAM, CO. DURHAM, DH1 1TW
Home Country United Kingdom
Nature of Business 74909 - Other professional, scientific and technical activities n.e.c.
Phone, email, etc

Since the company registration eight events have happened. The last three records are Total exemption small company accounts made up to 30 September 2016; Confirmation statement made on 12 September 2016 with updates; Total exemption small company accounts made up to 30 September 2015. The most likely internet sites of STRATEGIC PRE-CLINICAL PRODUCT DEVELOPMENT LIMITED are www.strategicpreclinicalproductdevelopment.co.uk, and www.strategic-pre-clinical-product-development.co.uk. The predicted number of employees is 1 to 10. The company’s age is eleven years and one months. Strategic Pre Clinical Product Development Limited is a Private Limited Company. The company registration number is 09234622. Strategic Pre Clinical Product Development Limited has been working since 25 September 2014. The present status of the company is Active. The registered address of Strategic Pre Clinical Product Development Limited is C O Westwaters Oakmere Belmont Business Park Durham Co Durham Dh1 1tw. . MISTRY, Kish is a Director of the company. REECE-JONES, Richard Peter is a Director of the company. The company operates in "Other professional, scientific and technical activities n.e.c.".


Current Directors

Director
MISTRY, Kish
Appointed Date: 25 September 2014
59 years old

Director
REECE-JONES, Richard Peter
Appointed Date: 25 September 2014
69 years old

Persons With Significant Control

Mr Kish Mistry
Notified on: 1 July 2016
59 years old
Nature of control: Ownership of shares – More than 25% but not more than 50%

Mr Richard Peter Reece-Jones
Notified on: 1 July 2016
69 years old
Nature of control: Ownership of shares – More than 25% but not more than 50%

STRATEGIC PRE-CLINICAL PRODUCT DEVELOPMENT LIMITED Events

02 Dec 2016
Total exemption small company accounts made up to 30 September 2016
12 Sep 2016
Confirmation statement made on 12 September 2016 with updates
24 Feb 2016
Total exemption small company accounts made up to 30 September 2015
28 Sep 2015
Annual return made up to 25 September 2015 with full list of shareholders
Statement of capital on 2015-09-28
  • GBP 100

28 Sep 2015
Director's details changed for Mr Kish Mistry on 28 September 2015
28 Sep 2015
Director's details changed for Mr Richard Peter Reece-Jones on 28 September 2015
13 Nov 2014
Statement of capital following an allotment of shares on 25 September 2014
  • GBP 100

25 Sep 2014
Incorporation
Statement of capital on 2014-09-25
  • GBP 10,000